Glaucoma Awareness

The company’s IOPerfect combines artificial intelligence in a VR-like headset to allow tele-diagnosis and remote monitoring of glaucoma.

Alcon this week announced its plans to acquire glaucoma surgery device maker Ivantis Inc. in a $475 million deal.

Investigators in Australia are developing a new rapid screening test for glaucoma that could help advance early detection of the disease.

A coalition of vision groups held a briefing on Capitol Hill this week to educate legislators on increasing incidence of myopia and the associated cost burden.

To mark World Sight Day, Nanodropper Inc. has developed a pay-it-forward Nanodropper Adaptor program, allowing anyone to donate devices to a pool for distribution to patients in need.

TearClear to start clinical trial for TC-002 latanoprost ophthalmic solution 0.005%.

New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.

There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.

According to preliminary results, intranasally delivered ST266 is a safe treatment option.

George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’

A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

New World Medical relied on feedback from surgeons in the development of the device, which was registered with the FDA in October.

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Researchers must weigh emotional, financial, and reputational considerations

Trabeculectomy may offer better results with more severe glaucoma

Technology is off to a good start, but improvements still needed

Diagnostic and monitoring advances in glaucoma need fine-tuning

With an eye on innovation, money is driving research of new therapies and devices.

Industry develops creative approaches to help increase patient medication adherence

Panel discusses IOP monitoring, drug delivery, data collection

For many physicians, “moral injury” may be actual issue

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma

There are other mimickers of NTG that should be kept in mind

New products increase the chance of early diagnosis

New therapies on the horizon offer options for slowing progression

Novel technologies range from invasive to non-invasive approaches

Marijuana, a non-traditional therapy for most medical problems, may have a bright future in glaucoma treatment based on its mechanism of action in the eye.

Patients with glaucoma have a three to four times greater risk of falling, which exceeds the risks associated with age-related macular degeneration, cataract, or diabetes. Here are some steps clinicians can share with their patients to help reduce falls.

Mobile apps designed to improve and facilitate adherence of patients with glaucoma to their treatment regimens are a step in the right direction but not all may achieve their goal, according to one researcher.